Pharmaceutical Development

Our comprehensive service offering includes early stage formulation and analytical development for both highly potent and non-potent drug products.

We are able to offer API directly into capsules and vials using micro-dosing technology as well as the more traditional development pathways. The use of micro-dosing drug in capsule (DIC) and drug in vial (DIV) approach offers both time and cost efficiencies as well as the potential to reduce wastage of often expensive APIs.

Following early stage development, we continue with further development, scale-up and process validation ahead of commercial launch for a variety of dosage forms, all supported by full in-house analytical development and release laboratory.

Our dedicated team of specialists will be happy to discuss any of your Pharmaceutical Development needs. Contact us on +1 779-208-1819 (US) or +44 1495 711 222 (UK/EU) or email

Start your PCI experience today.

Rely on our pharmaceutical development services. Your drug product means the world to us.

Spanning the cycle.A truly global proposition.

Always growing, we are driving development and connecting commercialization, and with 4300 people in 30 global GMP facilities, we are always close.